Contrasting VSee Health (VSEE) and Its Competitors

VSee Health (NASDAQ:VSEE – Get Free Report) is one of 93 publicly-traded companies in the “Healthcare Technology” industry, but how does it weigh in compared to its competitors? We will compare VSee Health to related companies based on the strength of its earnings, risk, dividends, valuation, institutional ownership, profitability and analyst recommendations.

Profitability

This table compares VSee Health and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
VSee Health -92.36% -11,636.34% -68.62%
VSee Health Competitors -749.77% -27.84% -15.02%

Institutional and Insider Ownership

1.0% of VSee Health shares are held by institutional investors. Comparatively, 42.4% of shares of all “Healthcare Technology” companies are held by institutional investors. 14.9% of VSee Health shares are held by insiders. Comparatively, 16.2% of shares of all “Healthcare Technology” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for VSee Health and its competitors, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
VSee Health 1 0 0 0 1.00
VSee Health Competitors 456 1539 2761 89 2.51

As a group, “Healthcare Technology” companies have a potential upside of 50.20%. Given VSee Health’s competitors stronger consensus rating and higher probable upside, analysts plainly believe VSee Health has less favorable growth aspects than its competitors.

Volatility & Risk

VSee Health has a beta of 0.2, indicating that its share price is 80% less volatile than the S&P 500. Comparatively, VSee Health’s competitors have a beta of 1.11, indicating that their average share price is 11% more volatile than the S&P 500.

Valuation and Earnings

This table compares VSee Health and its competitors revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
VSee Health $14.46 million -$14.71 million -0.01
VSee Health Competitors $340.07 million -$24.15 million 12.15

VSee Health’s competitors have higher revenue, but lower earnings than VSee Health. VSee Health is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

VSee Health competitors beat VSee Health on 11 of the 13 factors compared.

About VSee Health

(Get Free Report)

VSee Health provides telehealth technology and virtual-care services to healthcare organizations. Its offerings include a software platform for connecting patients and clinicians through virtual visits and supporting the delivery of care remotely. The company also combines its technology with clinical services through iDoc Telehealth, which provides virtual-care support to hospitals and other healthcare providers. Together, these businesses serve organizations seeking to extend access to care and coordinate services across in-person and remote settings.

Receive News & Ratings for VSee Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VSee Health and related companies with MarketBeat.com's FREE daily email newsletter.